239610 — HL Science Co Income Statement
0.000.00%
- KR₩63bn
- KR₩37bn
- KR₩18bn
- 44
- 27
- 12
- 14
Annual income statement for HL Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 143,036 | 104,375 | 52,758 | 25,587 | 17,664 |
Cost of Revenue | |||||
Gross Profit | 109,814 | 77,739 | 36,509 | 15,898 | 7,320 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 119,407 | 89,605 | 53,362 | 30,280 | 27,527 |
Operating Profit | 23,629 | 14,771 | -604 | -4,692 | -9,863 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 24,785 | 15,935 | 969 | -2,506 | -8,290 |
Provision for Income Taxes | |||||
Net Income After Taxes | 19,642 | 13,534 | 1,530 | -1,391 | -7,966 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 19,642 | 13,539 | 1,592 | -1,376 | -7,877 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 19,642 | 13,539 | 1,592 | -1,376 | -7,877 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3,728 | 2,601 | 304 | -271 | -1,546 |
Dividends per Share |